Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.

New model predicts HCC risk in noncirrhotic chronic hepatitis B patients, improving early detection strategies.

Unresectable canine hepatocellular carcinoma (HCC) has limited nonsurgical treatment options. Sorafenib is a targeted therapy for unresectable canine HCC. However, there are limited reports on the ...

These are liver cells under microscopy. At the top, in a healthy liver, the liver cells are organized normally. At the bottom, an accumulation of fat (white circles) is visible.

Amezalpat has been granted FDA fast track designation as treatment for patients with hepatocellular carcinoma.

Amezalpat is an investigational oral, small molecule, selective peroxisome proliferator-activated receptor-alpha antagonist.

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...